(Bartlett, Tennessee) – The American College of Apothecaries (ACA) was founded in 1940 in Richmond, Virginia to empower passionate pharmacy professionals to provide exceptional patient care in thriving community practices. ACA conducts educational programs, facilitates networking and mentoring, and promotes leadership that empowers pharmacy professionals to provide exceptional patient care.
The Waypoint Company (Waypoint) was formed in 2010 and serves over 800 pharmacy businesses in helping them create a plan to achieve their true purpose during and after their life in pharmacy. Their sole purpose is to protect and empower pharmacy owners because they believe successful, locally owned businesses bring greater vitality to the families and communities they serve.
Through this partnership, ACA and Waypoint look forward to serving independent pharmacy owners to find ways to generate revenue outside of the PBM model, and better serve their communities.
Matt Coakley, CEO of Waypoint, is excited to expand their services to ACA members. “We’re excited to continue to serve independent pharmacy owners and help them find ways to serve their communities and look beyond just filling prescriptions,” said Coakley.
One of the most overlooked lines on a pharmacy profit and loss statement are the employee benefits. This is why the Pharmacy401k team has decided to launch the first annual pharmacy employee benefits survey. This will allow other pharmacies to benchmark their benefits against pharmacies in their state, region and across the United States.
Overview: One of the American College of Apothecaries’ strengths is the open sharing of ideas — which historically has been accomplished through in-person meetings. ACA is augmenting these meetings by establishing expert faculties that will assemble using digital technology — including Zoom, Microsoft Teams, email, and online forums. Participation in faculty meetings is intended to increase member engagement, thus facilitating peer-to-peer networking and relationship building.
Member in all classes: Faculty participation is optional and offered to ACA members at all individual membership levels, which include our Fellows, pharmacists, student pharmacists, pharmacy technicians, pharmacy marketers, and affiliates. Faculties will thus seasoned pharmacy professionals to interact and share their expertise and experiences with others who have high interest levels and are in the process of establishing their expertise. Each faculty will elect a Chair and Chair-Elect who will serve for one-year terms.
Meetings of faculty: Meetings of faculty will focus on topics about which members are passionate — and could include but not limited to discussions of specific products, techniques and methods, concepts, issues, and opportunities. Because meetings will not involve the awarding of continuing education credit, the discussions will not be restricted by ACPE guidelines. Hence, speakers at meetings of faculty could include representatives or organizations that provide proprietary items to our members.
Founding faculty sponsors: ACA is seeking financial support of organizations that are aligned with the expertise and interests of one or more of our faculties — and that desire to be designated “Founding Faculty Sponsor”.
The ACA New Member Bundle is accredited for 3.0 contact hours (0.3 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
Opportunities in Wellness: Integrating Advanced Point of Sale Functional Testing in Community Pharmacy — Hillary Howell, PharmD, CCN, FACA / 1 CE
Long Walk Out of the Woods: A Physician’s Story of Addiction, Depression, Hope, and Recovery — Adam Hill, MD / 1 CE
Safeguard Your Compounding Pharmacy: Quality Control Tests for Dosage Forms and Common Pitfalls — Thomas C. Kupiec, PhD / 1 CE
Shortly after joining ACA, new members will receive a “Welcome Email” with a code to receive the ACA New Member Bundle at no cost*. Current members and non-members can purchase the bundle here:https://www.lecturepanda.com/a/NewMember
Dr. Hillary Howell, PharmD, FACA, CCN worked as a pharmacy technician until graduating high school in 1998. Her passion for medicine led her to enroll in the Doctor of Pharmacy program at Ferris State University and graduated in 2004. Shortly after graduating, she married her high school sweetheart and took a position as a retail staff pharmacist at a local pharmacy chain. This ultimately led to a manager position with the same company.
Hillary has two children, Hunter and Tanner, which she adores. 10 years into her position as a manager, her husband James was diagnosed with a rare type of cancer, leiomyosarcoma of the prostate. During his journey, the family decided to look into alternative treatments using both conventional and alternative therapies. Sadly, James’ journey ended 18 months later.
As a single mother, Hillary decided to take her career in a new direction. She opened Michigan’s first integrative cash based pharmacy, Apothecary & Co, in 2019, focusing on helping others to find their root cause instead of applying a “bandaid”. Apothecary & Co proudly specializes in compounding, point of care testing, and functional medicine consulting. Since opening in 2019, Hillary received her Certified Clinical Nutrition designation in 2021. She is currently pursuing a certification program through the Institute for Functional Medicine. Besides the love for functional medicine, her other passion is medicinal herbalism leading her to complete coursework through Rosemary Gladstar’s The Science of Art and Herbalism program.
Dr. Adam B. Hill, MD is a palliative care physician at Riley Hospital for Children. He is a proud Hoosier, a Butler Bulldog, and an IUSM graduate. He completed his pediatric residency training at St. Louis University, a fellowship in pediatric hematology/oncology at Duke University, and a palliative medicine fellowship at IUSM. His work in palliative care is focused on allowing patients to live the best quality of life possible in the midst of chronic, life-limiting, and/or life-threatening medical conditions.
In addition to palliative care, Dr. Hill is passionate about physician wellness/self-care, physician education, and international medical work. His international work has allowed him to work in Belize, Mexico, Kenya, Tanzania, and Australia over the past several years. In addition, as part of his work in palliative care, he serves as the medical director for a week-long summer camp for children affected by childhood cancer.
Dr. Thomas C. Kupiec, PhD is the CEO of ARL Bio Pharma and DNA Solutions Inc. Dr. Kupiec received his Ph.D. in Pharmaceutical Sciences from the University of Oklahoma Health Sciences Center College of Pharmacy. He currently serves as a graduate faculty member at the OU Health Sciences Center and has held teaching appointments at several universities. He has published numerous articles and abstracts in a variety of fields including pharmaceutical sciences, forensic sciences, and pharmacogenomics. Dr. Kupiec is often requested as a speaker at national pharmaceutical conferences and has spoken at ASHP, IACP, ACA, and state pharmaceutical associations.
Dr. Kupiec’s vision of entrepreneurial research is manifested by his responsibilities at DNA Solutions and ARL, which include supplying technical expertise and business development in the pharmaceutical and forensic fields. Additionally, Dr. Kupiec offers consultation services for a variety of pharmacy-related fields as well as expert witness testimony in the fields of forensic toxicology and pharmaceutical sciences. He has testified in over a hundred cases, both civil and criminal, in federal, state, and municipal courts.
His professional experience includes various appointments at Northwest Toxicology Inc. (NWT), the Federal Aviation Administration (FAA), and the Oklahoma City Police Department. Dr. Kupiec is affiliated with numerous professional organizations, including the American Academy of Forensic Sciences, the American Association of Pharmaceutical Scientists, the American Society of Health-System Pharmacists, the Society of Forensic Toxicologists, and Sigma Xi, The Scientific Research Society.
MOORESTOWN, N.J., November 16, 2020 — Tabula Rasa HealthCare (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, announces today a strategic alliance with the American College of Apothecaries (ACA). ACA, a national pharmacy organization dedicated to the advancement of professional practice in independent community pharmacy through entrepreneurship, will provide its members the ability to license TRHC’s medication safety software, MedWise™ and the opportunity to become MedWise Certified Advisors™ through TRHC.
“Partnering with Tabula Rasa HealthCare provides our members with access to innovative technologies, like MedWise, that will help them improve medication safety in patients who have a high burden of disease and complex medication regimens.” said ACA Executive Vice President/CEO Susan Bartlemay, RPh, FACA, FAPhA. “Our collaboration with TRHC furthers ACA’s commitment to providing exemplary pharmacy resources to community pharmacists.”
TRHC’s MedWise software provides science-based, actionable clinical intelligence to pharmacists, including a patient’s MedWise Risk Score™ (MRS). The MRS calculation uses active medication ingredients of a patient’s complete medication list, including over-the-counter supplements to predict the risk of medication problems and adverse drug events (ADEs). A published study, involving nearly 2,000 patients, found that a lower MRS correlated with fewer adverse drug events, emergency department visits, hospitalizations, and lower medical costs.
“As a former President of ACA, I understand how vital innovation and new technologies are in keeping community pharmacists at the top of their profession,” states TRHC Chairman and CEO Calvin H. Knowlton, PhD. “ Offering ACA members a way to identify high risk patients, and the opportunity to become certified MedWise Advisor™ is just the beginning of how our partnership will help improve medication safety in patients who are at risk for adverse drug events, due to their complex medication regimens.”
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides medication safety solutions empowering healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. Additionally, TRHC offers an extensive clinical telepharmacy network across the U.S. Our suite of solutions are trusted by health plans and pharmacies nationwide to help drive value-based payment results. For more information, visit TRHC.com
About the American College of Apothecaries
For 80 years, the American College of Apothecaries (acainfo.org) has been dedicated to the advancement of professional practice in independent community pharmacy through education, entrepreneurship, and mentoring. The Fellows and members of ACA are committed to best practices in pharmacy and quality healthcare for their communities.
ACA offers a way for pharmacists, pharmacy technicians, marketers, and students to connect with other pharmacy professionals to discuss areas of mutual interest and strengthen individual practice. This effort is supported through webinars, on-demand continuing education (CE), compounding classes, conferences and other events. ACA’s educational programming is available to all pharmacy professions, including non-members.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 2, 2020, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
ACA Fellows and Members have exclusive access to a 20% discount to the MedWise™ Decision Support Program. Click below to take advantage of this opportunity, and to elevate your pharmacy workflow through one-of-a-kind, science-based decision support tools.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.